SSbD bio-based solutions for home and/or personal care

Closed

Programme Category

EU Competitive Programmes

Programme Name

Circular Bio-based Europe Joint Undertaking

Programme Description

The Circular Bio-based Europe Joint Undertaking (CBE JU) is a €2 billion partnership between the European Union and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bio-based industries in Europe.

CBE JU is operating under the rules of Horizon Europe, the EU’s research and innovation programme, for the 2021-2031 period. The partnership is building on the success of its predecessor, the Bio-based Industries Joint Undertaking (BBI JU), while addressing the current challenges facing the industry.

 

Programme Details

Identifier Code

HORIZON-JU-CBE-2026-IAFlag-03

Call

SSbD bio-based solutions for home and/or personal care

Summary

The home and personal care sector, including fast-moving consumer goods (FMCG) and cosmetics, is a key industry where sustainability and performance challenges and demands are high. SSbD and competitive bio-based solutions are needed, for instance, for solvents, surfactants, preservatives, antimicrobial and antifungals agents, disinfectants, film forming agents, emulsifiers, emollients, exfoliants and abrasives, stabilisers, polymers and thickeners, conditioning agents, active ingredients, and other functional compounds.

Detailed Call Description

Despite advancements at demo scale in green chemistry and biotechnologies, further effort is needed to bridge innovation gaps and demonstrate at industrial scale the production of SSbD bio-based alternatives to conventional chemicals and ingredients, while maintaining/enhancing key functional properties in end-products/ formulations, such as physical stability, shelf life, efficacy, prevention of bioaccumulation and biodegradability.

Proposals under this topic should:

  • Demonstrate (at TRL 8) the production of SSbD bio-based solution(s) as an alternative to conventional chemicals, ingredients and combinations thereof, that are currently used in the formulation of home and/or personal care products (including cosmetics). SSbd bio-based chemicals/ingredients and biotechnology solutions are both in scope. Materials entering the end product formulation (e.g., granulates, powders, microbeads, micro/nano cellulose) are also in scope, while other materials related to home and personal care applications (e.g., nonwovens, other wipes, packaging) are out of scope.
  • Demonstrate (at TRL 7 and above) the application of the bio-based solution(s) into the formulation of market relevant end-product(s). Assess technical performances of end-product(s), ensuring that their final properties meet market application requirements. Adding new functionalities for specific applications is also in scope. While the topic focuses primarily on home and personal care applications, the demonstrated solution(s) could also be applicable to industrial production processes. When this is the case, validation (at TRL 6) of the industrial use case should be addressed.
  • Test that the release and accumulation of pollutants and harmful substances in the water is being avoided, including microplastics. When biodegradable solutions are targeted, validate biodegradability according to applicable EU/international standards, depending on the substance group and the final application(s).

In addition to the specific requirements applicable for the type of action, as described in section 2.2.3.1 of the CBE JU Annual Work Programme 2026, proposals under this topic should:

  • As part of the multi-actor approach (MAA), involve end-users, including brand owners and consumers when applicable, starting from the early stages to assess market acceptance of the targeted end-products and incorporate insights into product development.
  • Assess the safety of targeted bio-based solutions and end-products adopting standards and protocols in line with EU regulatory requirements for the selected application sector(s).
  • Include a task to identify potential regulatory gaps and provide recommendations to overcome potential bottlenecks.
  • Include a task to apply the SSbD framework, developed by the European Commission for the assessment of targeted chemicals/solutions and derived bio-based product(s). For more information on the SSbD framework and criteria, refer to Safe and sustainable by design.
  • Ensure complementarities with past and ongoing R&I projects addressing similar challenges, including projects funded under Horizon 2020/Horizon Europe (under Cluster 6 and other Clusters of Horizon Europe) and BBI JU/CBE JU projects.

Call Total Budget

€20.000.000

Financing percentage by EU or other bodies / Level of Subsidy or Loan

EU contribution: €20.000.000

Thematic Categories

  • Health
  • Industry
  • Processing
  • Research, Technological Development and Innovation

Eligibility for Participation

  • Businesses
  • Large Enterprises
  • Other Beneficiaries
  • Researchers/Research Centers/Institutions
  • Small and Medium Enterprises (SMEs)

Eligibility For Participation Notes

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects.

Call Opening Date

23/04/2026

Call Closing Date

22/09/2026